investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Fraser Symmans

1 Collaborator(s)

Funding source

University of Texas MD Anderson Cancer Center

No posts

Related projects

Valen Earl Johnson

Consistent Model Selection in the p>>n Setting

Breast

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Breast

Pathology

Pierre-Alexandre Vidi

Interplay Between Tissue Architecture and Nuclear Organization in the DNA Damage

Breast

Bert W O'Malley

Sex Hormone Receptor Components and the Cell Genome

Breast

Carlo M Croce

MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment

Breast

Filippo G Giancotti

Mechanisms governing metastatic reactivation of breast cancer.

Breast

David E Goldgar

A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum

Breast

Barbara M Mueller

A Novel Plasminogen Receptor in Breast Cancer

Breast

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Breast